News | 19/06/2026 | News
Diversity, Identity & Fate at Biomedical Frontiers
The BMC Diversity Initiative has invited three distinguished Munich-based scientists to present their current research in translational optoacoustics (Miguel Pleitez), lipid metabolism and metabolic diseases (Susanna Hofmann), and oncolytic virus-based cancer immunotherapeutics (Jennifer Altomonte). They will also share insights into the key experiences and challenges that have defined their careers in research. Meet-the-speaker sessions following the talks will offer opportunities for questions and open discussion.